Nyxoah Archives | Page 14 of 15

Home / Posts tagged Nyxoah (Page 14)

Nyxoah Announces Launch of Proposed Public Offering in the United States

Mont-Saint-Guibert, Belgium, June 25 (Korea Bizwire) – Nyxoah SA (Euronext Brussels: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced that it is launching an underwritten registered public offering of 2,760,000 ordinary shares in the United States (the “Offering”) at an assumed public [...]

Nyxoah Issues First Quarter 2021 Results

Mont-Saint-Guibert, Belgium, June 10 (Korea Bizwire) – Nyxoah SA (Euronext Brussels: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced its unaudited, interim financial statements for the three months ended March 31, 2021. In addition, Mr. Janke Dittmer has informed [...]

Nyxoah files Registration Statement for Proposed Initial Public Offering in the United States

Mont-Saint-Guibert, Belgium, June 10 (Korea Bizwire) – Nyxoah SA (Euronext Brussels: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced that the Company has publicly filed a registration statement on Form F-1 with the U.S. Securities and Exchange Commission [...]

Nyxoah BETTER SLEEP Trial Reaches its Primary Endpoints

Mont-Saint-Guibert, Belgium, June 7 (Korea Bizwire) – (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced that the BETTER SLEEP trial reached its primary safety and performance endpoints. The BETTER SLEEP trial was designed to assess the long-term safety and [...]

Publication Relating to a Transparency Notification

Mont-Saint-Guibert (Belgium), May 26 (Korea Bizwire) – In accordance with article 14 of the Act of 2 May 2007 on thedisclosure of large shareholdings, Nyxoah SA (Euronext Brussels: NYXH) announces that it received a transparency notification as detailed below. On 21 May 2021, Nyxoah received a transparency notification from BNP Paribas Asset Management SA following the acquisition of voting securities or voting rights on 19 May 2021 after which BNP Paribas Asset Management SA (through its affiliates BNP Paribas Asset Management France SAS and [...]

Invitation to Attend the Annual Shareholders’ Meeting of the Company to be Held on 9 June 2021

Mont-Saint-Guibert, Belgium, May 7 (Korea Bizwire) — NYXOAH SA (Euronext Brussels: NYXH) (hereinafter the “Company”) – The board of directors of the Company is pleased to invite its securities holders to attend the annual shareholders’ meeting of the Company, to be held on Wednesday, 9 June 2021 at 2:00 p.m. CET at the Company’s seat, or at such other [...]

Nyxoah Announces Submission of Draft Registration Statement for Proposed Public Listing in the United States

Mont-Saint-Guibert, Belgium, April 19 (Kore aBizwire) – Nyxoah SA (Euronext Brussels: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced that it has confidentially submitted a draft Registration Statement on Form F-1 to the Securities and Exchange Commission (the [...]

Nyxoah Reports Full Year 2020 Results

Mont-Saint-Guibert, Belgium, April 9 (Korea Bizwire) – Nyxoah SA (Euronext Brussels: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today reported financial and operating results for the full year ended December 31, 2020. Olivier Taelman, Chief Executive Officer of Nyxoah, [...]

Nyxoah to Delay Full Year 2020 Earnings Release Until April 9, 2021

Mont-Saint-Guibert, Belgium, April 2 (Korea Bizwire) – Nyxoah SA (Euronext Brussels: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions and services to treat Obstructive Sleep Apnea (OSA), today announced that it will delay its full year 2020 earnings release and subsequent conference call, previously scheduled for [...]

Nyxoah Announces the Publication of First Positive Clinical Data in an OSA Patient Suffering from Complete Concentric Collapse (CCC)

Mont-Saint-Guibert, Belgium, March 3 (Korea Bizwire) – Nyxoah SA (Euronext: NYXH) (“Nyxoah” or the “Company”), a health-technology company focused on the development and commercialization of innovative solutions and services to treat Obstructive Sleep Apnea (OSA), today announces the publication of an article presenting the first case of successful treatment of an OSA patient suffering from Complete Concentric [...]